All News

Safety monitoring findings for Shingrix are consistent with clinical trial data.

Pregnancy and menopause are contributing factors.

Scott Gottlieb’s tenure at the FDA was marked by hundreds of generic approvals and aggressive moves against the tobacco industry and vaping.

More than 40 companies have been recorded distributing nicotine-containing products to minors.

Poor medication adherence leads to $100 billion in healthcare expenditures annually.

Eli Lilly creates generic Humalog priced 50% lower 

A Canadian-based online pharmacy has been reissuing U.S. employee prescriptions from physicians and pharmaices in Canada, the United Kingdom, and Britain. 

As sunscreens have evolved, new safety considerations are warranted.

Increasing death tolls have prompted significant initiatives from governmental agencies.

Note the physiological signs of stress and consider necessary changes.

As drug dispensing continues to drive revenue, pharmacies look to shed retail.

Higher-dose tofacitinib linked to greater risk of pulmonary embolism in RA patients.

Learning a patient's specific situation might help overcome adherence barriers. 

State Senator Jeff Stone tackles PBM reform, reimbursement rates. 

Professional associations, gratitude can keep you engaged, healthy

How HHS efforts to increase competition could hurt patients.

Pharmacists must cultivate a culture of safety, training to protect patients.

Sublingual form approved for short-term use.

The new device will increase real-time personalization and predictive diagnostics for patients.

The report by Magellan Rx Management indicates PMPM, site of service, and Medicaid prices continue to increase. 

Pharmacies now may switch from accrual to cash accounting.

What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.

What you need to know about the new botulinum toxin product.

DOACs are as good as warfarin in preventing atrial fibrillation complications.

Three cardiology groups now recommend using NOACs over warfarin in atrial fibrillation.

Using healthcare professionals to market products is not illegal, but has gained considerable scrutiny from authorities.